About BDI biotech
BDI biotech is a company based in Valladolid (Spain) founded in 2014. BDI biotech has raised $4.78 million across 2 funding rounds from investors including Dyadic, La Moncloa and Inveready. BDI biotech offers products and services including Strain Development, Contract Productions, and Biotransformation. BDI biotech operates in a competitive market with competitors including Wacker Chemie, AMILI, Enduro, BioCina and Eleszto Genetika, among others.
- Headquarter Valladolid, Spain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.78 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Dyadic
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BDI biotech
BDI biotech offers a comprehensive portfolio of products and services, including Strain Development, Contract Productions, and Biotransformation.
Develops microbial strains for cosmetics and nutraceuticals.
Produces biomass and proteins for client needs.
Transforms by-products into ingredients for food and feed.
People of BDI biotech
Unlock access to complete
Unlock access to complete
Funding Insights of BDI biotech
BDI biotech has successfully raised a total of $4.78M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BDI biotech
BDI biotech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Dyadic, La Moncloa and Inveready.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Inveready is recognized as a leading Spanish financial services firm.
|
Locked | Locked | Locked | |
|
Official platform for Spanish government news and activities.
|
Locked | Locked | Locked | |
|
Microbial platforms are developed for biologic vaccine and drug applications.
|
Locked | Locked | Locked |
Investor details for BDI biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BDI biotech
Investment portfolio details for BDI biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BDI biotech
Detailed financials for BDI biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bdi Biotech Comparisons
Peer comparison for BDI biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BDI biotech
BDI biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wacker Chemie, AMILI, Enduro, BioCina and Eleszto Genetika, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Silicones, polymers, and bio-solutions are manufactured for various industries.
|
|
| Locked | Locked | Locked |
Gut microbiome insights, analytics, tests, and therapeutics are provided.
|
|
| Locked | Locked | Locked |
Microbial strains are manufactured by Enduro as a CDMO.
|
|
| Locked | Locked | Locked |
CDMO offering microbial expression systems-based biologics development and manufacturing services
|
|
| Locked | Locked | Locked |
CDMO offers microbial expression systems-based biologics development
|
|
| Locked | Locked | Locked |
Offers microbial expression systems-based biologics development and manufacturing services
|
Detailed competitors of BDI biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bdi Biotech
Complete news archive for BDI biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BDI biotech
BDI biotech was founded in 2014 and raised its 1st funding round 4 years after it was founded.
BDI biotech is headquartered in Valladolid, Spain. It is registered at Valladolid, Castilla Y Leon, Spain.
BDI biotech is a funded company, having raised a total of $4.78M across 2 funding rounds to date.
BDI Biotech is a biotechnology company offering biopharma drug development services through its expertise in product expression under different platforms (yeast, bacteria, and fungi), upstream and downstream process development, scale-up and contract manufacturing. The company has two main divisions namely BDI Health and BDI Food. The company has developed a patented and proprietary antigen-display nanoplatforms based on Virus-Like Particles (VLPs). These VLPs are empty and non-infectious structures that mimic real viruses and are capable of inducing both humoral and cellular responses. They have capabilities to incorporate pathology-associated antigens into VLPs for generating chimeric nanoparticles (Ch-VLPs). The company has developed CerviVax, an immunotherapeutic vaccine focused on the treatment of HPV-16HPV-18 (Human Papilloma Virus) infections and cervical dysplasia which has shown promising results in in-vivo efficacy and POC studies.
BDI biotech's top competitors include Wacker Chemie, AMILI and Enduro.
BDI biotech offers Strain Development, Contract Productions, and Biotransformation.
BDI biotech has 3 investors. Key investors include Dyadic, La Moncloa, and Inveready.